Breakthrough peptide inhibitor effective against multiple SARS-CoV-2 variants

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors.

How AI can help satisfy FDA’s drug, device diversity requirements

The Food and Drug Omnibus Reform Act of 2022 (FDORA), which was passed as part of the Consolidated Appropriations Act of 2023, will encourage greater

April 19, 2024

Sandoz inks $275M settlement in generic antitrust litigation

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

December 18, 2024

AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns

A breath test supported by artificial intelligence achieved 94% accuracy for detecting four common types of cancer, including 95% accuracy for detecting early disease. (Scientific

December 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.